Task: Answer the multiple choice question.
Query: Which compound exhibits a 19.389% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCC(C)(C)C1CCC2(CC1)NC(=S)N(c1ccccc1)N2
b: CCCn1c(SCC(=O)Nc2cc(Cl)ccc2Cl)n[nH]c1=O
Answer: a. CCC(C)(C)C1CCC2(CC1)NC(=S)N(c1ccccc1)N2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)(C)C1CCC2(CC1)NC(=S)N(c1ccccc1)N2
CCC(C)(C)C1CCC2(CC1)NC(=S)N(c1ccccc1)N2
8-(2-methylbutan-2-yl)-2-phenyl-1,2,4-triazaspiro[4.5]decane-3-thione